Notes / Company

iSERA Lifesciences Ltd.

COVIDH BSE 534920 ISIN INE899M01020 IT - Software

Fundamentals

Market cap: ₹104 cr
P/E: 401.58×
ROE: 0.00%
Debt / equity: -16.38
52-week range: 1.50 — 121.74

Research on Tijori Finance

Company snapshot

iSERA Lifesciences Ltd.

Software Services

₹65 cr

P/E 250.62×

Latest quarter · Mar 2019

Sales₹4 cr

Net profit−₹0 cr

Op. margin+5.7%

EPS−₹0.03

Strength & growth

Debt / equity22.04×

Current ratio1.84×

Sales CAGR−25.4%

EPS CAGR+6328.1%

The timeline — 1 note on iSERA Lifesciences Ltd.

May 2026

21 May 26 · 7:57 PM IST Brief

Brief · Earnings · Micro cap

iSERA Lifesciences posts FY26 profit of ₹25.94 lakhs

The company reported its annual audited results, showing a strong finish in Q4 as it pivots into software and IT services.

Verify on exchange BSE filings for COVIDH NSE filings for COVIDH Tijori Finance company page